Cross Country Healthcare, Inc.
4.98%
1,631,864
1141103
227483104
Dec 7, 2025
Dec 10, 2025, 10:02 AM
Reporting Persons (4)
This is a joint filing. The reported shares may overlap between reporting persons and should not be summed.
| Name | Type | % of Class | Aggregate | Sole Voting | Shared Voting |
|---|---|---|---|---|---|
| Magnetar Financial LLC | Investment Adviser | 4.98% | 1,631,864 | 0 | 1,631,864 |
| Magnetar Capital Partners LP | Holding Company | 4.98% | 1,631,864 | 0 | 1,631,864 |
| Supernova Management LLC | Holding Company | 4.98% | 1,631,864 | 0 | 1,631,864 |
| David J. Snyderman | Individual | 4.98% | 1,631,864 | 0 | 1,631,864 |
Disclosure Items (5)
Common Stock, par value $0.0001 per share
Cross Country Healthcare, Inc.
6551 Park of Commerce Boulevard, N.W., Boca Raton, FL, 33487
As of the close of business December 8, 2025, each of the Reporting Persons may have been deemed to have beneficial ownership of 1,631,864 Shares, which consisted of (i) 1,006,099 Shares held for the benefit of PRA Master Fund, (ii) 429,589 Shares held for the benefit of Systematic Master Fund, (iii) 95,738 Shares held for the benefit of Relative Value Master Fund, and (iv) 100,438 Shares held for the benefit of the Managed Accounts, and all such Shares represented beneficial ownership of approximately 4.98% of the Shares.
As of the close of business December 8, 2025, each of the Reporting Persons may have been deemed to have beneficial ownership of 1,631,864 Shares, which consisted of (i) 1,006,099 Shares held for the benefit of PRA Master Fund, (ii) 429,589 Shares held for the benefit of Systematic Master Fund, (iii) 95,738 Shares held for the benefit of Relative Value Master Fund, and (iv) 100,438 Shares held for the benefit of the Managed Accounts, and all such Shares represented beneficial ownership of approximately 4.98% of the Shares.
The response to Item 4 of this Amendment No. 3 is incorporated herein by reference. The Reporting Persons sold an additional 183,678 Shares in aggregate totaling $1,476,097.58 (excluding commissions and other execution-related costs) on behalf of the Funds since the filing of the Schedule 13D on December 8, 2025.
No other person is known by the Reporting Persons to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, any Shares that are beneficially owned by the Reporting Persons.
As of the close of business December 8, 2025, the Reporting Persons ceased to be beneficial owners of more than five percent of the Shares.
N/A
99.1 Joint Filing Agreement, dated as of December 10, 2025, among the Reporting Persons. 99.2 Power of Attorney, dated as of December 22, 2022 filed by the Reporting Persons on December 10, 2025.